Based on the abundance of CD4+ and CD8+ T cells and their penetration into the tumor, tumor immune profiles can be classified into “cold” or “hot” tumors or more precisely into the immune-inflamed phenotype, the immune-excluded phenotype, or the immune-desert phenotype, which are different in immunotherapy response [19]. This evidence concerns the gene CD8A and neoplasm.